BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35030969)

  • 1. High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling.
    Xi X; Hu Z; Wu Q; Hu K; Cao Z; Zhou J; Liao J; Zhang Z; Hu Y; Zhong X; Bao Y
    Bioengineered; 2022 Jan; 13(1):1895-1907. PubMed ID: 35030969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA Small Nucleolar RNA Host Gene 3 Mediates Prostate Cancer Migration, Invasion, and Epithelial-Mesenchymal Transition by Sponging miR-487a-3p to Regulate
    Yu L; Ren Y
    Cancer Biother Radiopharm; 2022 Aug; 37(6):451-465. PubMed ID: 33416420
    [No Abstract]   [Full Text] [Related]  

  • 3. SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
    Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X
    Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
    Jiang H; Li X; Wang W; Dong H
    BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway.
    Shi J; Li J; Yang S; Hu X; Chen J; Feng J; Shi T; He Y; Mei Z; He W; Xie J; Li S; Jie Z; Tu S
    J Cell Physiol; 2020 Mar; 235(3):2891-2900. PubMed ID: 31602642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer.
    Li T; Xing Y; Yang F; Sun Y; Zhang S; Wang Q; Zhang W
    Cancer Med; 2020 Jun; 9(11):3852-3862. PubMed ID: 32248648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X
    Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
    Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
    [No Abstract]   [Full Text] [Related]  

  • 10. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
    Hong L; Chen W; Wu D; Wang Y
    Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-485-3p promotes proliferation, migration and invasion in prostate cancer through activation of TGF-β signaling.
    Chen D; Fan J; Li X; Jiao Z; Tang G; Guo X; Chen H; Wang J; Men T
    Histol Histopathol; 2022 May; 37(5):423-430. PubMed ID: 34958117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y
    Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state.
    Kwon W; Choi SK; Kim D; Kim HG; Park JK; Han JE; Cho GJ; Yun S; Yu W; Han SH; Ha YS; Lee JN; Kwon TG; Cho DH; Yi JK; Kim MO; Ryoo ZY; Park S
    J Exp Clin Cancer Res; 2021 Sep; 40(1):291. PubMed ID: 34537073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
    Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
    Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
    Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
    Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
    Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D
    Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1.
    Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
    Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
    J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
    Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
    J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
    Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
    FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.